UCB Epilepsy Drug Fenfluramine Shows Positive Phase 3 Results
UCB Reports Positive Phase 3 Results for Epilepsy Drug Fenfluramine in Rare CDD Disorder BRUSSELS – Global biopharmaceutical company UCB announced Thursday that…
AstraZeneca Set to Showcase New Cancer Research at ASCO 2024
Plenary Presentations Highlight Tagrisso and Imfinzi’s Potential in Early Lung Cancer London, UK – This Tuesday, AstraZeneca confirmed that it is set to…
Update: Merck Invests €300 Million in New Bio-Pharmaceutical Research Center
German Chancellor Olaf Scholz and Merck Celebrate Laying for Advanced Research Facility Darmstadt, Germany — This Thursday, Merck announced an investment of over…